Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5892043 | Bone | 2011 | 6 Pages |
Abstract
Paget's disease is the best example of a common high turnover bone disease. A review of the early use of bisphosphonates in the treatment of this condition shows that many of the fundamental therapeutic issues were identified using drugs which by today's standards were far from ideal. Over the succeeding decades there has been a steady increase in potency culminating in the introduction of intravenous zoledronic acid which is capable of inducing long term remissions which were unthinkable when bisphosphonates were first introduced.This article is part of a Special Issue entitled Bisphosphonates.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Ian R. Reid, D.J. Hosking,